Introduction
Materials and methods
Patients
Surgical technique
Outcomes
Statistical analysis
Results
Baseline characteristics (Table 1)
Transperineal APE N = 32 | ||
---|---|---|
Sex | Male (%) | 24 (75.0) |
Female (%) | 8 (25.0) | |
BMI kg/m2 (mean) (± SD) | 26.4 (3.3) | |
Age,years (mean) (± SD) | 65.7 (12.8) | |
ASA class | I | 1 (3.1) |
II | 25 (78.1) | |
III | 6 (18.8) | |
Tumour height from ARJ (cm)* | Mean (± SD) | 0.50 (0.87) |
Median (range) | 0 (0–3.0) | |
T-stage (%) | cTis | 1 (3.1) |
cT2 | 7 (21.9) | |
cT3 | 17 (53.1) | |
cT4b | 7 (21.9) | |
N-stage (%) | N0 | 18 (56.3) |
N1 | 8 (25.0) | |
N2 | 6 (18.8) | |
M-stage (%) | M + | 1 (3.1)** |
Mesorectal fascia involved | Yes | 21 (65.6) |
No | 11 (34.4) | |
EMVI | Yes | 8 (25.0) |
No | 18 (56.3) | |
Unknown | 6 (18.8) | |
Ingrowth | No | 16 (50.0) |
Spinctercomplex | 10 (31.3) | |
M. levator ani | 4 (12.5) | |
Prostate / vagina | 2 (6.3) | |
Neoadjuvant radiotherapy (%) | No | 9 (28.1) |
5 × 5 short interval | 3 (9.4) | |
long course Chemorad | 20 (62.5) |
Transperineal APE N = 32 | ||
---|---|---|
Type of surgery | APE, levators left in situ | 8 (25.0) |
Unilateral ELAPE | 7 (21.9) | |
Bilateral ELAPE | 17 (53.1) | |
Beyond TME resection | No | 24 (75.0) |
Prostate/Vagina | 6 (18.8) | |
Seminal vesicles | 1 (3.1) | |
Ovaries | 1 (3.1) | |
Pelvic sidewall | 0 (0) | |
Operative time (min) | Mean (± SD) | 278 (78) |
Median (range) | 249 (175–450) | |
Blood loss (ml) | Mean (± SD) | 203 (115) |
Median (range) | 200 (50–400) | |
Conversion | To open perineal dissection | 1 (3.1) |
To laparotomy | 0 (0) | |
Intraoperative events | Urethral injury | 1 (3.1) |
Pelvic sidewall injury | 1 (3.1) | |
Co2 embolism | 1 (3.1) | |
Rectal tube perforation | 2 (6.3) | |
Omentoplasty performed | Yes | 6 (18.8) |
Perineal reconstruction | Primary closure | 18 (56.3) |
Gluteal turnover flap* | 3 (9.4) | |
Gluteus maximus flap** | 3 (9.4) | |
Non-absorbable mesh | 1 (3.1) | |
Absorbable mesh | 7 (21.9) |
Primary endpoint
Secondary endpoints
Transperineal APE N = 32 | ||
---|---|---|
Mortality (30 day) | 0 (0) | |
Total postoperative complications CD | None | 11 (34.4) |
Minor (CD I-II) | 18 (56.3) | |
Major (CD ≥ III) | 3 (9.4) | |
Perineal wound healing | uncomplicated | 17 (53.1) |
complicated | 15 (46.9) | |
Nature of healing complications | Superficial infection | 10 (31.3) |
Break through abscess | 4 (12.5) | |
Flap failure | 1 (3.1) | |
Days to heal (days) median (range) | Uncomplicated | 14 (5–60) |
Complicated | 45 (21–140) |
Transperineal APE N = 32 | ||
---|---|---|
Pathology stage | (y)pT0 | 4 (12.5) |
(y)pT1 | 0 (0) | |
(y)pT2 | 9 (28.1) | |
(y)pT3 | 19 (59.4) | |
Successful resection | Yes | 5 (15.6) |
No | 27 (84.4) | |
Quality of specimen (Quirke)* | Complete | 15 (48.4) |
Nearly complete | 13 (41.9) | |
Incomplete | 3 (9.7) | |
CRM involvement (< 1 mm) | Yes | 4 (12.5) |
No | 28 (87.5) | |
Perforation | Yes | 2 (6.3) |
No | 30 (93.8) | |
Lymph nodes harvested | Mean (± SD) | 13.6 (7.9) |
Median (range) | 12 (2–34) | |
Pathologic N stage | (y)pN0 | 20 (62.5) |
(y)pN1 | 9 (28.1) | |
(y)pN2 | 3 (9.4) |
Comparative analysis
APE n = 8 | Unilateral ELAPE n = 7 | Bilateral ELAPE n = 17 | p value | ||
---|---|---|---|---|---|
Baseline | |||||
Sex | Male (%) | 7 (87.5) | 6 (85.7) | 11 (64.7) | 0.488 |
Female (%) | 1 (12.5) | 1 (14.3) | 6 (35.3) | ||
Age, years | Mean (± SD) | 70.3 (7.1) | 69.3 (13.7) | 62.0 (14.0) | 0.241 |
Median (range) | 71 (55–80) | 70.0 (47–86) | 63.0 (33–83) | ||
BMI kg/m2 | Mean (± SD) | 28.3 (2.5) | 25.0 (3.6) | 26.1 (3.3) | 0.121 |
Median (range) | 28.2 (25.5–31.5) | 24.9 (20.3–30.7) | 25.6 (20.2–33.0) | ||
ASA class | < III | 7 (87.5) | 4 (57.3) | 15 (88.2) | 0.202 |
≥ III | 1 (12.5) | 3 (42.7) | 2 (11.8) | ||
Tumour stage (cT) | ≤ T3 | 7 (87.5) | 3 (42.7) | 15 (88.2) | 0.054 |
T4 | 1 (12.5) | 4 (57.3) | 2 (11.8) | ||
Mesorectal fascia threatened | Yes (%) | 3 (37.5) | 6 (85.7) | 12 (70.6) | 0.146 |
No (%) | 5 (62.5) | 1 (14.3) | 5 (29.4) | ||
Height with respect to ARJ | At or below (%) | 6 (75.0) | 2 (28.6) | 14 (82.4) | 0.045 |
Above (%) | 2 (25.0) | 5 (71.4) | 3 (17.6) | ||
Intraoperative outcomes | |||||
Operative time (minutes) | Mean (± SD) | 256 (50) | 245 (50) | 297 (83) | 0.250 |
Median (range) | 242 (175–300) | 245 (175–300) | 300 (180–450) | ||
Intraoperative complications | Yes (%) | 0 (0) | 3 (42.9) | 2 (11.8) | 0.071 |
No (%) | 8 (100) | 4 (57.3) | 14 (82.4) | ||
Pathological outcomes | |||||
Quality of specimen (Quirke) | Complete | 6 (75.0) | 5 (71.4) | 4 (25.0) | 0.022 |
Nearly complete | 1 (12.5) | 1 (14.3) | 11 (68.8) | ||
Incomplete | 1 (12.5) | 1 (14.3) | 1 (6.3) | ||
CRM involvement | Yes (%) | 1 (12.5) | 2 (28.6) | 1 (5.9) | 0.306 |
No (%) | 7 (87.5) | 5 (71.4) | 16 (94.1) | ||
Perforation | Yes (%) | 0 (0) | 2 (28.6) | 0 (0) | 0.042 |
No (%) | 8 (100) | 5 (71.4) | 17 (100) | ||
Successful resection | Yes (%) | 7 (87.5) | 5 (71.4) | 15 (84.4) | 0.679 |
No (%) | 1 (12.5) | 2 (28.6) | 2 (15.6) | ||
Postoperative outcomes | |||||
Severe 30 day morbidity (CD ≥ 3) | Yes (%) | 1 (12.5) | 1 (14.3) | 1 (5.9) | 0.781 |
No (%) | 7 (87.5) | 6 (85.7) | 16 (94.1) | ||
Days to perineal wound healing | Mean (± SD) | 44.0 (39.0) | 25.8 (16.6) | 51.2 (36.9) | 0.354 |
Median (range) | 33 (5–106) | 22 (7–45) | 42 (6–140) | ||
Perineal wound healing | Uncomplicated | 3 (37.5) | 4 (57.1) | 10 (58.8) | 0.709 |
Superficial infection | 5 (50.0) | 1 (14.3) | 5 (29.4) | ||
Omental/Break- through abscess | 1 (12.5) | 2 (28.6) | 1 (5.9) | ||
Flap failure | 0 (0) | 0 (0) | 1 (5.9) |